◀ Back to IL1A
CCL5 — IL1A
Text-mined interactions from Literome
Kim et al., J Neurochem 2004
:
Ribonuclease protection assay and ELISA showed that IFNbeta, although not effective alone, increased
IL-1 induced
RANTES/CCL5 expression, but did not antagonize IFNgamma ... IL-1 or
IL-1/IFNbeta induced
RANTES/CCL5 expression was inhibited by the super-repressor IkappaBalpha or inhibitors of p38 or c-Jun N-terminal kinase (JNK) MAPKs ( mitogen activated protein kinases ), but not by extracellular signal regulated kinases ( ERK ) inhibitors ... Transfection with mutated RANTES/CCL5 promoter-reporter constructs revealed that kappaB, interferon stimulated response element ( ISRE ) and CAATT-enhancer binding protein-beta ( C/EBPbeta ) sites all contributed to
IL-1/IFNbeta induced
RANTES/CCL5 transcription
Wolf et al., PloS one 2011
:
It also enhances TAB1 dependent
CCL5 secretion in
response to
IL-1 and increases activity of a post-transcriptional reporter gene, which contains the CCL5 3 ' untranslated region
Alexander et al., Physiol Genomics 2012
(Inflammation...) :
Finally, immunofluorescent staining of mouse atherosclerotic lesions revealed the presence of cells positive for the marker of an
IL-1ß stimulated inflammatory SMC,
chemokine (C-C motif) ligand 20 ( CCL20 ), but not the PDGF-DD induced gene, regulator of G protein signaling 17 ( RGS17 )